HALO Clinical AI

Looking Back: Reviewing 2024 at Indica Labs

As 2024 draws to a close, we at Indica Labs would like to thank the customers and collaborators who helped fill 2024 with exciting discoveries, events, and partnerships. It is a great honor to have played a part in customers’ contributions to scientific fields ranging from immuno-oncology to infectious disease, immunology, neuroscience, and metabolism.

Looking Back: Reviewing 2024 at Indica Labs Read More »

The Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) Selects Indica Labs’ HALO AP® to Deliver AI-enabled Diagnostics

Albuquerque, NM, October 30, 2024 – The Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), among the leading institutes for clinical digital pathology and research in the European Union, has partnered with Indica Labs to implement digital primary diagnostics with integrated AI-powered image analysis.

The Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) Selects Indica Labs’ HALO AP® to Deliver AI-enabled Diagnostics Read More »

Indica Labs’ London HALO® User Group Meeting 2024

10 December 2024 | Indica Labs is pleased to announce our London HALO User Group Meeting to be held in London on 10 December 2024 at Hilton London Metropole from 12:00 – 16:00.

Indica Labs’ London HALO® User Group Meeting 2024 Read More »

2024 Pathology Visions Pre-Conference Workshop Abstract for Indica Labs

3 November 2024 | In this one-hour pre-conference workshop, Indica Labs is pleased to host Dr. Eun Yeong Oh, MD, PhD, Assistant Regional Medical Director, Subchief of Breast Pathology, and Physician AI Champion at Mid-Atlantic Permanente Medical Group (MAPMG), who will present on the validation and implementation of a laboratory developed test using Breast IHC AI in the HALO AP® platform.

2024 Pathology Visions Pre-Conference Workshop Abstract for Indica Labs Read More »

Indica Labs Announces Launch of AI-Powered Macrodissection Suite to Advance Molecular Pathology Workflows

Albuquerque, NM – 1 August 2024 – Indica Labs, the leading provider of AI-powered digital pathology solutions, proudly announces the launch of Lung Macrodissect AI, a groundbreaking tool that revolutionizes slide macrodissection and molecular pathology workflows.

Indica Labs Announces Launch of AI-Powered Macrodissection Suite to Advance Molecular Pathology Workflows Read More »

Indica Labs Expands Availability of HALO Digital Pathology Solutions in Asia Pacific Region Including CE-IVDR Marked HALO AP® Platform

Albuquerque, NM – 2 July 2024 – Indica Labs today announces the expansion of their reseller network in the Asia Pacific (APAC) region.

Indica Labs Expands Availability of HALO Digital Pathology Solutions in Asia Pacific Region Including CE-IVDR Marked HALO AP® Platform Read More »

HALO Macrodissection Solutions: Enhancing the Accuracy of Personalized Oncology Through AI-Powered Slide Macrodissection

Lung Macrodissect AI identifies and highlights non-small cell lung cancer cells present on whole slide images to guide annotations for downstream automated slide macrodissection.

HALO Macrodissection Solutions: Enhancing the Accuracy of Personalized Oncology Through AI-Powered Slide Macrodissection Read More »

Indica Labs’ Preconference Workshop Pathology Visions 2023

29 October 2023 | In this one-hour pre-conference workshop, Indica Labs is pleased to host Dr. David Dorward, Consultant Thoracic Pathologist at the Royal Infirmary of Edinburgh, who will present on the development of artificial intelligence (AI) tools for the diagnosis and treatment of lung cancer.

Indica Labs’ Preconference Workshop Pathology Visions 2023 Read More »

Towards Open Pathology: Facilitating Development of Novel AI-based Tools for Digital Pathology through Collaboration and Integration

16 October 2022 | In this 1-hour workshop, Eric Runde, Chief Operating Officer at Indica Labs, will introduce Indica’s platforms, our collaborative approach to incorporating artificial intelligence (AI) into life science and clinical workflows, and the open pathology tools available to developers and industry partners. Dr. Peter Caie, Principal Scientist of AI Collaborations at Indica Labs, will present case studies of customer collaborations resulting in the development and validation of commercially available and inter-operable AI algorithms addressing customer needs.

Towards Open Pathology: Facilitating Development of Novel AI-based Tools for Digital Pathology through Collaboration and Integration Read More »

Scroll to Top